Claim being evaluated

Improves gastrointestinal conditions

A claim to investigate, not an established benefit. Each outcome below is assessed separately.

What the evidence suggests

Clinical response or remission: No eligible human study addressing this question was found. This is not evidence that there is no effect.

Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated by rule (no eligible human study was found), not reviewed by a person.

Certainty by outcome

Clinical response or remission

Insufficient information to assess

Patient-important outcome · 0 studies

Not enough evidence to tell

No eligible human study addressing this question was found. This is not evidence that there is no effect.

Reviewers’ note: No eligible human study addressing this question was found. This is not evidence that there is no effect.

How the certainty was judged
GRADE domain judgments
DomainJudgmentWhy
Starting level—
Risk of bias—
Inconsistency—
Indirectness—
Imprecision—
Publication bias—

Included studies

    Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · GRADE (handbook, 2013) · Automated by rule (no eligible human study was found), not reviewed by a person.

    The questions and the studies screened

    Population, intervention, comparator and outcome (PICO), and why each study was or wasn’t eligible.

    Population: People with inflammatory bowel disease or another gastrointestinal condition · Intervention: BPC-157 (any route studied) · Comparator: Placebo or usual care · Outcome: Clinical response or remission

    Version history

    • Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated by rule (no eligible human study was found), not reviewed by a person.

    How claims are assessed

    These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).